bioRxivImmunologyPreprint
Highly functional Cellular Immunity in SARS-CoV-2 Non-Seroconvertors is associated with immune protection
A. Kilpelainen, E. Jimenez-Moyano, O. Blanch-Lombarte, D. Ouchi, R. Penya, B. Quirant-Sanchez, A. Chamorro, I. Blanco, E. Martinez-Caceres, R. Paredes, L. Mateu, J. Carrillo, J. Blanco, C. Brander, M. Massanella, B. Clotet, J. G Prado
Abstract
The role of T cells in the control of SARS-CoV-2 infection has been underestimated in favor of neutralizing antibodies. However, cellular immunity is essential for long-term viral control and protection from disease severity. To understand T-cell immunity in the absence of antibody generation we focused on a group of SARS-CoV-2 Non-Seroconvertors (NSC) recovered from infection. We performed an immune comparative analysis of SARS-CoV-2 infected individuals stratified by the absence or presence of seroconversion and disease severity. We report high levels of total naive and low effector CD8+ T cells in NSC. Moreover, polyfunctional Nucleocapsid (NP)-specific CD8+ T-cell responses, as well as reduced levels of T-cell activation monitored by PD-1 and activation-induced markers, were distinctive immunological traits in NSC. Longitudinal data support the stability of the NSC phenotype over three months. Our results implicate highly functional SARS-CoV-2 Spike and NP T-cell responses with low immune activation in protection from disease severity in the absence of seroconversion. SUMMARYTo understand SARS-CoV-2 specific T-cell immunity in the absence of seroconversion, we characterized immunological features of Non-Seroconvertors recovered from infection. Highly functional specific T-cell responses and low immune activation were determinants of immune protection from severe disease.
- organism: human
- assay: flow cytometry
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
- Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
N. Le Bert, H. E. Clapham, … C. C. Tam·bioRxiv·Nov 25, 2020
- Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response
A. Perez-Gomez, M. C. Gasca-Capote, … E. Ruiz-Mateos·bioRxiv·Dec 28, 2021
- Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
T. Sekine, A. Perez-Potti, … Karolinska COVID-19 Study Group·bioRxiv·Jun 29, 2020
- Durability of SARS-CoV-2-specific T cell responses at 12-months post-infection
Z. Lu, E. D. Laing, … A. M. Malloy·bioRxiv·Aug 11, 2021
- SARS-CoV-2-specific T cells exhibit unique features reflecting robust helper function, lack of terminal differentiation, and high proliferative potential
J. Neidleman, X. Luo, … N. R. Roan·bioRxiv·Jun 8, 2020